-
UR Associates has come out with its report pharma sector. According to the research firm, Indian pharma companies including its foreign subsidiaries have received 171 ANDA approvals.
-
UR Associates has come out with its report on pharmaceutical sector. According to the research firm, the ceiling price of the 348 drugs included in the NLEM 2011 would be determined by simple average price of all the brands having market share more than and equal to 1% of the total market turnover of that medicine.
-
UR Associates has come out with its report on infrastructure sector. According to the research firm, there are around 100 projects of over Rs 10 bn awaiting clearances from various ministries.
-
UR Associates has come out with its report on infrastructure sector. According to the research firm, the Insurance Regulatory and Development Authority (IRDA) carried out a detailed review of the existing investment regulation including the requirement to facilitate a higher flow of insurance funds to infrastructure sector.
-
UR Associates has come out with its report on pharmaceutical sector. According to the research firm, the Indian Cabinet has approved the long pending National Pharmaceutical Pricing Policy, which would bring 348 drugs under the ambit of price control.
-
UR Associates has come out with its report on infra sector.
-
UR Associates has come out with its report on infra sector. According to the research firm, Planning Commission of India had projected an investment worth Rs 20,561.50 bn for the XIth Five Year Plan (2007-12) as compared to an investment of Rs 9,160.76 bn realised during the Xth Plan (2002-07).
-
UR Associates has come out with its report on pharma sector. According to the research firm, new pharma pricing policy to be finalized in November.
-
UR Associates has come out with its report on pharma sector. The research firm says the Q1 FY13 performance of pharma companies was strong driven by revival in domestic market performance, strong exports to the emerging markets and exports further aided by rupee depreciation. Expect the strong quarterly performance to continue in Q2 FY13 too.
-
UR Associates has come out with its report on infrastructure sector. According to the research firm, infrastructure sector could a benefit if the Reserve Bank of India cuts interest rates as per expectation in the coming monetary policy.
-
UR Associates has come out with its report on infrastructure sector. According to the research firm, NHAI also has a provision for providing grant up to 40% of the project cost to make projects commercially viable. However, the quantum of grant is decided on a case to case basis and typically constitutes the bid parameter in BOT projects.
-
UR Associates has come out with its report on pharma sector. According to the research firm, the new pharma pricing policy will impact most of the companies in the domestic market including some large Indian companies like Ranbaxy, Cipla, Lupin and Cadila who are expected to have an earnings impact of 5%-10%.
-
UR Associates has come out with its report on infra space. The GDP growth rate achieved in the 10th Plan was at 7.6% and in the 11th Plan it was 7.9%.
-
UR Associates has come out with its report on pharma space. According to research firm FIPB approved 8 FDI brownfield proposals.
-
UR Associates has come out with its report on infrastructure sector. According to the research firm, Indian Railways has identified Public Private Partnership (PPP) investment in Railways in the 12th Five Year Plan in a number of areas.
-
UR Associates has come out with its report on pharmaceutical sector. According to the research firm, domestic pharma companies need to target key fast growing pharmerging markets of Japan, Russia and Brazil, and focus on biologics as a strategy of future growth.
-
UR Associates has come out with its report on agri sector. According to the research firm, Rashtriya Chemicals and Fertilisers (RCF) will invest Rs 40 billion in next three years to ramp up its urea capacity at Thal plant near Mumbai. The selection process for lumpsum turnkey contractors (LSTK) for main plants has been completed.
-
UR Associates has come out with his report on Infrastructure sector. The research firm says during the Japanese Prime Minister‘s visit to India in December, 2011, Japan offered to match Government of India‘s contribution to DMIC Project by announcing a contribution of $ 4.5 bn for projects with Japanese participation.
-
UR Associates has come out with his report on pharma sector. According to research firm, Indian pharma companies received 29% of total US FDA generic drug approvals during the April-August period.
-
UR Associates has come out with its report on agriculture sector. The research firm says monsoon rainfall has been near normal during August but coarse cereals and pulses sowing still lagging behind normal. The monsoon deficiencies in the other regions are Central India (10%), South Peninsula (19%) and East and NorthEast India (13%).
-
UR Associates has come out with its report on pharma sector. According to the research firm overall pharmaceutical industry was pegged at Rs 1,000 billion (~USD 20 billion) with the domestic pharma industry at over Rs 600 billion (~USD 12 billion) in 2009-10.
-
UR Associates has come out with its report on infra sector. According to research firm recent focus by the government to speed up infrastructure projects and regular monitoring of the projects is step in the right direction.
-
UR Associates has come out with its report on agri sector. According to the research firm, better rainfall has increased the water levels in the 84 major reservoirs in India which will help to increase electricity production which will in turn result in more number of hours of electricity supply for our farm sector.
-
UR Associates has come out with its report on agri space.
-
UR Associates has come out with its report on infra space.
